MCL1 and B-cell chronic lymphocytic leukemia: In order to assess the contribution of Mcl-1 in determining a reduction to venetoclax response, we compared the viability of +12 CLL cells transfected with Notch2 siRNA or scramble control both treated with venetoclax for 24 h.